Focus on Lipids Care

Back to articles

Statins are associated with development of diabetes in a high-risk population

December 4, 2017
  • Advising on this article:
  • Amber L. Briggs

KEY POINT

Statin use was associated with an increased incidence of type 2 diabetes (T2D) in patients who were at high risk of developing diabetes, according to a 10-year analysis of data from the Diabetes Prevention Program (DPP) trial published in BMJ Open Diabetes Research and Care.

SOURCES

Crandall JP, et al. Statin use and risk of developing diabetes: Results from the Diabetes Prevention Program. BMJ Open Diab Res Care. 2017;[Epub ahead of print].

FDA. FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs. Accessed November 13, 2017.

Recent Articles

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

More info

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.